Search research articles
Contact Us
Filters
Showing results (131-140 of 191) with videos related to
Page
of 20
Sort By:
BMC Pharmacology & Toxicology
|
December 15, 2017
The clinical efficacy of Afatinib 30 mg daily as starting dose may not be inferior to Afatinib 40 mg daily in patients with stage IV lung Adenocarcinoma harboring exon 19 or exon 21 mutations
Chih-Jen Yang, Ming-Ju Tsai, Jen-Yu Hung, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
May 19, 2010
Antiproliferative effect of Toona sinensis leaf extract on non-small-cell lung cancer
Chih-Jen Yang, Yu-Jung Huang, Cheng-Yuan Wang, et al.
Cancers
|
November 16, 2018
Better Progression-Free Survival in Elderly Patients with Stage IV Lung Adenocarcinoma Harboring Uncommon Epidermal Growth Factor Receptor Mutations Treated with the First-line Tyrosine Kinase Inhibitors
Ming-Ju Tsai, Jen-Yu Hung, Mei-Hsuan Lee, et al.
Carcinogenesis
|
August 20, 2013
Lung tumor-associated dendritic cell-derived resistin promoted cancer progression by increasing Wolf-Hirschhorn syndrome candidate 1/Twist pathway
Chih-Hsin Kuo, Kuei-Fang Chen, Shah-Hwa Chou, et al.
Oncotargets and Therapy
|
April 5, 2016
Poorer prognosis in Taiwanese female ever smokers with stage IV lung adenocarcinoma who were readministered a tyrosine kinase inhibitor
Chih-Jen Yang, Ming-Ju Tsai, Jen-Yu Hung, et al.
BMC Pharmacology & Toxicology
|
May 11, 2017
The salvage therapy in lung adenocarcinoma initially harbored susceptible EGFR mutation and acquired resistance occurred to the first-line gefitinib and second-line cytotoxic chemotherapy
Chih-Jen Yang, Jen-Yu Hung, Ming-Ju Tsai, et al.
Scientific Reports
|
May 13, 2016
Corrigendum: Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients
Ming-Ju Tsai, Ping-Hsun Wu, Chau-Chyun Sheu, et al.
Cancers
|
December 8, 2020
Systematic Review and Network Meta-Analysis of Immune Checkpoint Inhibitors in Combination with Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Carcinoma
Hsiao-Ling Chen, Yu-Kang Tu, Hsiu-Mei Chang, et al.
Scientific Reports
|
April 8, 2016
Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients
Ming-Ju Tsai, Ping-Hsun Wu, Chau-Chyun Sheu, et al.
Plos One
|
July 16, 2015
Erectile Dysfunction in Patients with Sleep Apnea--A Nationwide Population-Based Study
Chia-Min Chen, Ming-Ju Tsai, Po-Ju Wei, et al.
Page
of 20
Search research articles
Search
Showing results (131-140 of 191) with videos related to
Sort By:
Page
of 20
BMC Pharmacology & Toxicology
|
December 15, 2017
The clinical efficacy of Afatinib 30 mg daily as starting dose may not be inferior to Afatinib 40 mg daily in patients with stage IV lung Adenocarcinoma harboring exon 19 or exon 21 mutations
Chih-Jen Yang, Ming-Ju Tsai, Jen-Yu Hung, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
May 19, 2010
Antiproliferative effect of Toona sinensis leaf extract on non-small-cell lung cancer
Chih-Jen Yang, Yu-Jung Huang, Cheng-Yuan Wang, et al.
Cancers
|
November 16, 2018
Better Progression-Free Survival in Elderly Patients with Stage IV Lung Adenocarcinoma Harboring Uncommon Epidermal Growth Factor Receptor Mutations Treated with the First-line Tyrosine Kinase Inhibitors
Ming-Ju Tsai, Jen-Yu Hung, Mei-Hsuan Lee, et al.
Carcinogenesis
|
August 20, 2013
Lung tumor-associated dendritic cell-derived resistin promoted cancer progression by increasing Wolf-Hirschhorn syndrome candidate 1/Twist pathway
Chih-Hsin Kuo, Kuei-Fang Chen, Shah-Hwa Chou, et al.
Oncotargets and Therapy
|
April 5, 2016
Poorer prognosis in Taiwanese female ever smokers with stage IV lung adenocarcinoma who were readministered a tyrosine kinase inhibitor
Chih-Jen Yang, Ming-Ju Tsai, Jen-Yu Hung, et al.
BMC Pharmacology & Toxicology
|
May 11, 2017
The salvage therapy in lung adenocarcinoma initially harbored susceptible EGFR mutation and acquired resistance occurred to the first-line gefitinib and second-line cytotoxic chemotherapy
Chih-Jen Yang, Jen-Yu Hung, Ming-Ju Tsai, et al.
Scientific Reports
|
May 13, 2016
Corrigendum: Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients
Ming-Ju Tsai, Ping-Hsun Wu, Chau-Chyun Sheu, et al.
Cancers
|
December 8, 2020
Systematic Review and Network Meta-Analysis of Immune Checkpoint Inhibitors in Combination with Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Carcinoma
Hsiao-Ling Chen, Yu-Kang Tu, Hsiu-Mei Chang, et al.
Scientific Reports
|
April 8, 2016
Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients
Ming-Ju Tsai, Ping-Hsun Wu, Chau-Chyun Sheu, et al.
Plos One
|
July 16, 2015
Erectile Dysfunction in Patients with Sleep Apnea--A Nationwide Population-Based Study
Chia-Min Chen, Ming-Ju Tsai, Po-Ju Wei, et al.
Page
of 20